Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic Registry.
about
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryAdverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: a systematic review and meta-analysisEvolution of percutaneous coronary intervention in patients with diabetes: a report from the National Heart, Lung, and Blood Institute-sponsored PTCA (1985-1986) and Dynamic (1997-2006) RegistriesPaclitaxel-eluting versus sirolimus-eluting stents in diabetes mellitus: a report from the National Heart, Lung, and Blood Institute Dynamic Registry.Qualitative assessment of neointimal tissue after drug-eluting stent implantation: comparison between follow-up optical coherence tomography and intravascular ultrasound.Predictors of restenosis after percutaneous coronary intervention using bare-metal stents: a comparison between patients with and without dysglycemia.Full-metal jacket: A bad strategy.Temporal changes in the outcomes of patients with diabetes mellitus undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute dynamic registry.Paclitaxel- and sirolimus-eluting stents in older patients with diabetes mellitus: results of a real-life multicenter registry.Paclitaxel versus sirolimus eluting stents in diabetic patients: does stent type and/or stent diameter matter?: long-term clinical outcome of 2,429-patient multicenter registry.Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.The impact of diabetes mellitus on long-term clinical outcomes after percutaneous coronary saphenous vein graft interventions in the drug-eluting stent era.Titanium-nitride-oxIde-coated stents multicenter registry in diaBEtic patienTs: the TIBET registry.
P2860
Q22241786-D6ACDD19-2B00-41F1-B977-756C96648014Q26786265-A9660994-F90D-4327-A7D5-50F6DC87DBE3Q34084527-58A6336E-BBFC-4621-B0BD-E6B09F512FBDQ34162064-02CF490A-6136-44DC-9C51-7C7F5CD23EDAQ34775591-36FBDCB2-B767-489A-8272-E6D4BD8FD590Q43045641-57B6529A-0A99-4C01-B7CD-841453C63782Q44529237-94BFDA5E-E134-45DD-9F59-2E8FD92ADB3AQ45147928-0BC5E639-A7B0-414D-BC31-F94E0D7ED8C3Q45829740-1B320835-8216-46B3-AFCF-3318D43C6E31Q46066877-512DCB60-2D22-40F9-9379-CCB0A4FE1E6FQ46120002-AB850C28-19D8-43A2-8A64-8E14F2853378Q53492573-774C80B7-9803-4FDD-89A2-0689F7DDA4A8Q54069775-D95F98E0-E5D9-4E06-B99F-A939A5DE5673
P2860
Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic Registry.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of drug-eluting stents ...... od Institute Dynamic Registry.
@en
Impact of drug-eluting stents ...... od Institute Dynamic Registry.
@nl
type
label
Impact of drug-eluting stents ...... od Institute Dynamic Registry.
@en
Impact of drug-eluting stents ...... od Institute Dynamic Registry.
@nl
prefLabel
Impact of drug-eluting stents ...... od Institute Dynamic Registry.
@en
Impact of drug-eluting stents ...... od Institute Dynamic Registry.
@nl
P2093
P2860
P1476
Impact of drug-eluting stents ...... od Institute Dynamic Registry.
@en
P2093
Conrad Smith
David O Williams
Elizabeth M Holper
Faith Selzer
Helen A Vlachos
J Dawn Abbott
Joon S Lee
Kevin E Kip
Oscar C Marroquin
Sheryl F Kelsey
P2860
P304
P356
10.1016/J.JCIN.2008.02.005
P577
2008-04-01T00:00:00Z